Agaru
Aquilaria agallocha
Agaru (Aquilaria agallocha), or Agarwood, is a revered resinous heartwood in Ayurveda, known for its fragrant smoke and supposed balancing effect on Vata, Pitta, and Kapha doshas. Historically prized, it's used for its claimed soothing and warming properties, often found in traditional incense and formulations for respiratory and nervous system support.
PLANT FAMILY
Thymelaeaceae (Mezereon)
PARTS USED
Heartwood, Resin, Bark
AYURVEDIC ACTION
Vata ↓, Pitta ↑, Kapha ↓
ACTIVE COMPOUNDS
Agarospirol (15-20%)
What is Agaru?
Agaru, also known as Aquilaria agallocha, is a slow-growing evergreen tree belonging to the Thymelaeaceae family, native to the rainforests of Southeast Asia. It is most renowned for its fragrant, dark resinous heartwood, which is formed when the tree becomes infected with a specific mold (Phialophora parasitica). This highly prized wood, commonly known as oud or agarwood, is a valuable commodity in perfumery, incense, and traditional medicine.
The resinous wood is characterized by its complex and highly aromatic scent, which intensifies when burned. Historically, Agaru has been revered for its unique fragrance and therapeutic properties, playing a significant role in various cultural and religious practices across Asia.
Other Names of Agaru
- Oud
- Agarwood
- Aloeswood
- Eaglewood
- Gaharu

Heading
<h3> Absolute Contraindications of Agaru </h3> <h4> Pregnancy and Breastfeeding (Avoid internal use)</h4> <ul> <li> 🤰</li> <li> Recommendation: Do not take Agaru internally during pregnancy or while breastfeeding; topical or short, supervised uses may be discussed with a qualified clinician but oral ingestion should be avoided. </li> <li> Reasoning: Some Aquilaria extracts (leaf methanol extracts) showed DNA damage (genotoxicity) in human peripheral blood cells in laboratory tests; because genotoxic findings raise theoretical risks for developing embryos and gametes, internal use is not recommended in pregnancy or lactation until safety is proven. </li> <li> Scientific_Study_Title: Chemical constituents and toxicity effects of leaves from several agarwood tree species (Aquilaria).</li> <li> Scientific_Study_Authors: Adam AZ, Tajuddin SN, Sudmoon R, Chaveerach A, Abdullah UH, Mahat MN, Mohamed R.</li> <li> Scientific_Study_Link: https://hero.epa.gov/hero/index.cfm/reference/details/reference_id/5208628</li> <li> Scientific_Study_Excerpt: <p>The authors analysed essential oils and solvent extracts from leaves of three Aquilaria species and tested them against human peripheral blood mononuclear cells (PBMCs) using MTT (viability) and comet (DNA damage) assays. While most extracts showed limited cytotoxicity, the methanol extract of Aquilaria malaccensis produced significant cytotoxicity (IC50 ≈ 24.5 mg/mL) and induced DNA fragmentation with a comet-like appearance (p < 0.05) in PBMCs. The investigators conclude that, at the concentrations tested, some leaf extracts may be slightly hazardous and that genotoxic signals warrant caution for human consumption until further safety work is done.</p> <p>Because genotoxicity in human cells can theoretically affect dividing fetal cells or germ cells, the paper is used as a laboratory signal advising avoidance of internal ingestion during pregnancy and lactation in the absence of safety data.</p> </li> </ul> <h4> Active Respiratory Disease / Asthma / COPD (Avoid smoke/inhalation) </h4> <ul> <li> 😷</li> <li> Recommendation: Avoid inhaling Agaru smoke (burning chips, incense or repeated heavy indoor burning) if you have asthma, COPD or other chronic lung disease; if used, ensure strict ventilation or use non-smoke alternatives (diffusers). </li> <li> Reasoning: Burning incense produces particulate matter and carcinogenic volatile compounds; long-term or heavy exposure to incense smoke (including agarwood incense) is associated with airway irritation, worsening of asthma/COPD and increased risk of some respiratory tract cancers in epidemiological studies. </li> <li> Scientific_Study_Title: The Adverse Impact of Incense Smoke on Human Health: From Mechanisms to Implications.</li> <li> Scientific_Study_Authors: (Review) - multiple authors (see original article).</li> <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548258/</li> <li> Scientific_Study_Excerpt: <p>This comprehensive review summarises experimental, epidemiological and mechanistic studies on incense smoke exposure. Incense burning releases particulate matter (including PM2.5), polycyclic aromatic hydrocarbons (PAHs), volatile organic compounds and carbonyls. The paper reviews evidence that these emissions cause airway irritation, oxidative stress, inflammation and DNA damage; several population studies link long-term incense use to increased risk of upper respiratory tract squamous cell carcinoma and to worsened airway disease outcomes. The authors advise caution for prolonged indoor incense exposure, especially in poorly ventilated settings.</p> <p>The review places incense smoke in the broader context of indoor air pollution and recommends minimising direct inhalation exposure among vulnerable groups (children, those with respiratory disease, and the elderly).</p> </li> </ul> <h4> Known Allergy to Tree Resins / Fragrances (Avoid topical or inhalational exposure) </h4> <ul> <li> ⚠️</li> <li> Recommendation: If you have a history of contact dermatitis or fragrance allergy, avoid topical Agaru oil products and limit exposure to its smoke or perfumes; perform patch testing under supervision before broader topical use. </li> <li> Reasoning: Fragrance mixtures and tree resins are common causes of contact allergic dermatitis; aromatic compounds in agarwood can provoke hypersensitivity in susceptible people. Even when animal sensitization tests are negative, human patch testing may reveal individual reactions. </li> <li> Scientific_Study_Title: Contact allergy caused by fragrance mix and Myroxylon pereirae (balsam of Peru) - retrospective study (fragrance allergy context).</li> <li> Scientific_Study_Authors: Uter W, et al. (see article for full author list).</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21661358/</li> <li> Scientific_Study_Excerpt: <p>A large retrospective dermatology study examined patients with allergic contact dermatitis who were patch-tested to a standard fragrance mix and to balsam of Peru. A substantial proportion (≈16.6%) were allergic to the fragrance mix and multiple individual fragrance components (isoeugenol, eugenol, cinnamal). The study demonstrates that fragrances are a frequent sensitiser in the clinic and that individuals with fragrance allergy commonly react to multiple aromatic compounds. Although this paper does not test agarwood directly, it establishes the high background risk for allergic reactions to aromatic plant volatiles and supports clinical caution with aromatic resins such as Agaru in sensitised individuals.</p> </li> </ul> <h3> Relative Contraindications of Agaru </h3> <h4> Liver disease or elevated liver enzymes (Use with caution; consult physician)</h4> <ul> <li> 🩺</li> <li> Recommendation: Avoid high-dose or prolonged internal use of Agaru extracts if you have liver disease; speak with your doctor before use and monitor liver tests if advised. </li> <li> Reasoning: Some plant extracts from Aquilaria show effects on hepatic cell lines and gene expression; while animal studies at certain doses find no overt organ toxicity, cellular effects on hepatocyte gene regulation indicate caution in compromised livers. </li> <li> Scientific_Study_Title: Investigation of Cytotoxic, Antioxidant, Apoptotic/Necrotic Activity of Aquilaria agallocha Root Extract and Determination of Gene Expression Levels in HepG2, MCF-7 Cancer Cell Lines.</li> <li> Scientific_Study_Authors: (MDPI paper) - authors listed in the article (see link).</li> <li> Scientific_Study_Link: https://www.mdpi.com/2075-1729/15/4/651</li> <li> Scientific_Study_Excerpt: <p>This laboratory study assessed Aquilaria root extracts against human hepatoma (HepG2) and other cell lines. At specific concentrations some extracts produced cytotoxic effects in HepG2 cells and altered expression of genes associated with cell survival and apoptosis (including p53, Bax, Bcl-2). While in-vitro findings do not directly prove clinical hepatotoxicity, the changes in gene expression and cellular viability support a precautionary stance for patients with existing liver impairment or those taking multiple hepatically-metabolised medications.</p> <p>The authors recommend further mechanistic and safety testing prior to recommending high dose or long term human ingestion, especially in vulnerable populations.</p> </li> </ul> <h4> Children (especially infants) - avoid concentrated inhalation or internal dosing</h4> <ul> <li> 👶</li> <li> Recommendation: Do not give concentrated Agaru preparations (internal medicines, strong inhalational exposure) to infants or young children; if used in older children, use very low exposures under professional guidance. </li> <li> Reasoning: Sedative and CNS-modulating effects demonstrated in animal models mean doses that calm adults could overly depress respiration or consciousness in small children; exposure via smoke also risks respiratory irritation. </li> <li> Scientific_Study_Title: Agarwood Essential Oil Ameliorates Restrain Stress-Induced Anxiety and Depression by Inhibiting HPA Axis Hyperactivity.</li> <li> Scientific_Study_Authors: Wang S, Wang C, Yu Z, et al.</li> <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274913/</li> <li> Scientific_Study_Excerpt: <p>Animal behavioural studies found agarwood essential oil produced dose-dependent anxiolytic and antidepressant effects in mice and changed HPA axis markers (lowered CRF, ACTH, corticosterone). These central nervous system effects that reduce activity and stress responses in rodents imply that CNS depression is plausible at sufficient doses; translating such effects to children raises safety concerns because children are more sensitive to sedatives and respiratory depressants, and inhaled particulate matter can harm their developing lungs.</p> </li> </ul>
Heading
<h4> Respiratory irritation, cough, worsened asthma (Breathing problems)</h4> <ul> <li> 😮💨</li> <li> Side effect summary: Burning or heavy inhalation of Agaru incense can irritate the airways, trigger cough and wheeze, and worsen asthma or COPD symptoms. </li> <li> Recommendation: Stop exposure immediately; for mild symptoms ventilate area and consider antihistamine or inhaler if prescribed. Seek urgent care if breathing becomes difficult. </li> <li> Reasoning: Incense smoke contains PM2.5, PAHs and VOCs which provoke airway inflammation and oxidative stress-these mechanisms underlie observed respiratory harms in human studies. </li> <li> Severity Level: Severe</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Incense smoke: clinical, structural and molecular effects on airway disease.</li> <li> Scientific_Study_Authors: Chang SJ, et al. (see article for full list).</li> <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377255/</li> <li> Scientific_Study_Excerpt: <p>The review collates evidence that inhalation of incense smoke produces a range of airway effects: acute irritation, chronic airway inflammation, impaired lung function and associations with upper respiratory tract cancers in some populations. Mechanistically, incense emissions deliver particulate matter and chemical irritants that induce oxidative stress, cytokine production and structural airway changes. The authors summarise epidemiological and mechanistic studies, concluding that chronic or heavy exposure is harmful-particularly in poorly ventilated indoor environments or among persons with pre-existing respiratory disease.</p> </li> </ul> <h4> Allergic skin reactions / contact dermatitis </h4> <ul> <li> 🤕</li> <li> Side effect summary: Topical Agaru oil or prolonged contact with resinous materials can cause redness, itching or eczema in people with fragrance/resin sensitivity. </li> <li> Recommendation: Patch test small area before topical use; stop if rash or irritation appears. For severe reactions, seek dermatology care. </li> <li> Reasoning: Fragrance components commonly provoke contact allergic dermatitis; aromatic compounds in agarwood may act similarly in sensitised individuals. </li> <li> Severity Level: Moderate</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Contact allergy caused by fragrance mix and Myroxylon pereirae (balsam of Peru)--a retrospective study.</li> <li> Scientific_Study_Authors: Uter W, et al.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21661358/</li> <li> Scientific_Study_Excerpt: <p>This dermatology study shows that a notable fraction of patients tested for contact dermatitis reacted to standard fragrance mixes and balsam of Peru, with common allergens including isoeugenol and eugenol. While not specific to agarwood, the paper demonstrates that aromatic natural product components frequently act as sensitizers in humans-supporting clinical caution when applying fragrant plant oils or resins topically without prior testing.</p> </li> </ul> <h4> Hepatic cellular effects at higher concentrations (possible liver cell stress)</h4> <ul> <li> 🧪</li> <li> Side effect summary: High concentrations of some Aquilaria extracts showed changes in hepatocyte cell lines and markers of apoptosis in laboratory studies; clinical hepatotoxicity is not established but caution is advised. </li> <li> Recommendation: Avoid high-dose internal use if you have liver disease; monitor liver tests if advised by a clinician. </li> <li> Reasoning: In vitro hepatocyte responses (gene expression, apoptosis markers) indicate potential for hepatic cell stress at certain concentrations, although animal oral toxicology at tested doses has been reassuring. </li> <li> Severity Level: Moderate</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Investigation of Cytotoxic, Antioxidant, Apoptotic/Necrotic Activity of Aquilaria agallocha Root Extract and Determination of Gene Expression Levels in HepG2, MCF-7 Cancer Cell Lines.</li> <li> Scientific_Study_Authors: (MDPI article authors - see paper)</li> <li> Scientific_Study_Link: https://www.mdpi.com/2075-1729/15/4/651</li> <li> Scientific_Study_Excerpt: <p>Laboratory testing of Aquilaria root extracts demonstrated dose-dependent cytotoxicity in HepG2 cells at higher concentrations, with alterations in expression of p53, Bax and Bcl-2 genes-markers linked to cell survival and apoptosis. The authors emphasise in-vitro nature of the findings and call for in-vivo and clinical safety studies, but note that the cellular responses justify prudence in high-dose internal usage, especially in those with pre-existing liver conditions.</p> </li> </ul>
Heading
<h4> CNS depressants (benzodiazepines, sedative antihistamines, opioids, alcohol)</h4> <ul> <li> Interaction_Details: Agarwood essential oil and some aromatic constituents produce sedative and anxiolytic effects in animals; combining with other central depressants could increase drowsiness, slowed reaction time, or respiratory depression at sufficient doses. </li> <li> Severity: Moderate</li> <li> Recommendation: Avoid combining oral Agaru preparations or heavy inhalational exposure with prescription sedatives or alcohol without medical supervision; if necessary, consult your prescribing clinician first. </li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274913/</li> <li> Scientific_Study_Title: Agarwood Essential Oil Ameliorates Restrain Stress-Induced Anxiety and Depression by Inhibiting HPA Axis Hyperactivity.</li> <li> Scientfic_Study_Authors: Wang S, Wang C, Yu Z, et al.</li> <li> Scientific_Study_Excerpt: <p>In mouse models, inhalation or administration of agarwood essential oil produced clear sedative-hypnotic and anxiolytic effects on multiple behavioural assays (elevated plus maze, open field, forced swim). The oil reduced upstream HPA axis signals (CRF/CRFR) and downstream glucocorticoids (ACTH, corticosterone), consistent with central calming effects. These results indicate that agarwood bioactives modulate central stress and arousal systems; when combined with pharmaceutical CNS depressants, additive suppression of alertness or respiration is theoretically possible and merits caution.</p> </li> </ul> <h4> Drugs metabolised by the liver (CYP substrates) - theoretical caution</h4> <ul> <li> Interaction_Details: Some Aquilaria extracts affect hepatocyte gene expression in vitro; while direct pharmacokinetic interaction studies are lacking, these cellular effects raise a theoretical possibility of altered hepatic metabolism of co-administered drugs. </li> <li> Severity: Mild</li> <li> Recommendation: If you take medicines with a narrow therapeutic index that are mainly cleared by the liver, consult your clinician before starting internal Agaru preparations; consider monitoring drug levels when relevant. </li> <li> Scientific_Study_Available: Yes (mechanistic in vitro evidence only)</li> <li> Scientific_Study_Link: https://www.mdpi.com/2075-1729/15/4/651</li> <li> Scientific_Study_Title: Investigation of Cytotoxic, Antioxidant, Apoptotic/Necrotic Activity of Aquilaria agallocha Root Extract and Determination of Gene Expression Levels in HepG2, MCF-7 Cancer Cell Lines.</li> <li> Scientfic_Study_Authors: (see article)</li> <li> Scientific_Study_Excerpt: <p>The in-vitro study found that specific Aquilaria extracts altered expression of key genes in HepG2 liver cells (including p53 family and apoptosis regulators) and produced cytotoxicity at higher concentrations. Although no human pharmacokinetic interactions were measured, the authors note that cellular effects on hepatocytes could theoretically influence hepatic handling of other xenobiotics and recommend further safety and interaction studies before routine concurrent use with hepatically-metabolised drugs.</p> </li> </ul> <h4> Anticoagulants / Antiplatelet drugs (warfarin, DOACs, aspirin) - no direct evidence (theoretical)</h4> <ul> <li> Interaction_Details: There is no robust published evidence demonstrating that Agaru directly alters coagulation or platelet function in humans; some traditional texts caution about bleeding risk, but modern experimental anticoagulant data specific to Aquilaria are lacking. </li> <li> Severity: Mild</li> <li> Recommendation: Because reliable data are absent, if you take anticoagulant or antiplatelet medication avoid starting high-dose internal Agaru products without physician advice and routine monitoring of coagulation parameters if recommended. </li> <li> Scientific_Study_Available: NA</li> <li> Scientific_Study_Link: NA</li> <li> Scientific_Study_Title: NA</li> <li> Scientfic_Study_Authors: NA</li> <li> Scientific_Study_Excerpt: <p>There are no clear controlled studies on Aquilaria interacting with human anticoagulants. Traditional cautions exist but are not backed by dedicated pharmacology trials. Given the absence of direct evidence, interactions remain theoretical and warrant clinical prudence rather than definitive prohibition.</p> </li> </ul>